Literature DB >> 35983416

Variation in Patient-Described Barriers to and Facilitators of Diabetes Management by Individual-Level Characteristics: A Cross-Sectional, Open-Ended Survey.

David J T Campbell1,2,3, Harleen Ghuttora1, Ana Mladenovic4, Jordan Smith5, Ryan Leigh6, Laura Desveaux7, Noah Ivers7, Braden Manns1,2, Marcello Tonelli1,2, Christopher Naugler2,8, Brenda Hemmelgarn9, Kerry A McBrien2,10.   

Abstract

This study analyzed patient-described barriers and facilitators related to diabetes management, focusing on how these differ by glycemia and across individual characteristics. A cross-sectional telephone survey was conducted with adult patients with diabetes in Alberta, Canada, asking two open-ended questions to describe the most helpful and difficult components of their diabetes management. Responses were analyzed using directed content analysis using the Theoretical Domains Framework as a template. The most frequently cited facilitator was care context and information, and the most frequently cited barriers were cognitive challenges and structural barriers, with patient-perceived barriers and facilitators varying by individual-level factors.
© 2022 by the American Diabetes Association.

Entities:  

Year:  2022        PMID: 35983416      PMCID: PMC9331623          DOI: 10.2337/cd21-0060

Source DB:  PubMed          Journal:  Clin Diabetes        ISSN: 0891-8929


  37 in total

Review 1.  Content analysis: review of methods and their applications in nutrition education.

Authors:  Nancy L Kondracki; Nancy S Wellman; Daniel R Amundson
Journal:  J Nutr Educ Behav       Date:  2002 Jul-Aug       Impact factor: 3.045

2.  Suboptimal use of cardioprotective drugs in newly treated elderly individuals with type 2 diabetes.

Authors:  Caroline Sirois; Jocelyne Moisan; Paul Poirier; Jean-Pierre Grégoire
Journal:  Diabetes Care       Date:  2007-03-23       Impact factor: 19.112

3.  Understanding Financial Barriers to Care in Patients With Diabetes.

Authors:  David J T Campbell; Braden J Manns; Brenda R Hemmelgarn; Claudia Sanmartin; Alun Edwards; Kathryn King-Shier
Journal:  Diabetes Educ       Date:  2016-12-07       Impact factor: 2.140

Review 4.  Barriers to diabetes management: patient and provider factors.

Authors:  Soohyun Nam; Catherine Chesla; Nancy A Stotts; Lisa Kroon; Susan L Janson
Journal:  Diabetes Res Clin Pract       Date:  2011-03-05       Impact factor: 5.602

5.  Compliance with clinical practice guidelines for type 2 diabetes in rural patients: treatment gaps and opportunities for improvement.

Authors:  Ellen L Toth; Sumit R Majumdar; Lisa M Guirguis; Richard Z Lewanczuk; Tzu K Lee; Jeffrey A Johnson
Journal:  Pharmacotherapy       Date:  2003-05       Impact factor: 4.705

Review 6.  Economic costs of diabetes in the U.S. In 2007.

Authors: 
Journal:  Diabetes Care       Date:  2008-03       Impact factor: 19.112

7.  Health care costs in people with diabetes and their association with glycemic control and kidney function.

Authors:  Kerry A McBrien; Braden J Manns; Betty Chui; Scott W Klarenbach; Doreen Rabi; Pietro Ravani; Brenda Hemmelgarn; Natasha Wiebe; Flora Au; Fiona Clement
Journal:  Diabetes Care       Date:  2012-12-13       Impact factor: 19.112

8.  Barriers to care in patients with diabetes and poor glycemic control-A cross-sectional survey.

Authors:  Kerry A McBrien; Christopher Naugler; Noah Ivers; Robert G Weaver; David Campbell; Laura Desveaux; Brenda R Hemmelgarn; Alun L Edwards; Nathalie Saad; David Nicholas; Braden J Manns
Journal:  PLoS One       Date:  2017-05-01       Impact factor: 3.240

9.  Financial barriers and adverse clinical outcomes among patients with cardiovascular-related chronic diseases: a cohort study.

Authors:  David J T Campbell; Braden J Manns; Robert G Weaver; Brenda R Hemmelgarn; Kathryn M King-Shier; Claudia Sanmartin
Journal:  BMC Med       Date:  2017-02-15       Impact factor: 8.775

Review 10.  Exercise therapy in type 2 diabetes.

Authors:  Stephan F E Praet; Luc J C van Loon
Journal:  Acta Diabetol       Date:  2009-05-29       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.